-
Abstract Number: PB1121
Idarucizumab to Neutralize Dabigatran in a University Hospital: The Relevance of Renal Function
-
Abstract Number: PB1467
Idelalisib Selectively Inhibits GPVI-mediated Platelet Activation and Shows Anti-atherothrombotic Activity
-
Abstract Number: PB1452
Identification and Functional Study of a New Germline Variant in Mecom Gene
-
Abstract Number: PB0464
Identification of a Circulating Lipid Profile Associated with Venous Thromboembolism
-
Abstract Number: PB/CO04
Identification of a COVID-19 Subpopulation Responsive to Hydroxychloroquine Using Machine Learning: The IDENTIFY Trial
-
Abstract Number: PB0321
Identification of a Novel “Laminin G” Domain Mutant of Protein S Defective in Binding and Inhibiting FIXa and Unaffected in APC/TFPI Cofactor Activities
-
Abstract Number: PB1506
Identification of a Novel Molecular Variant in the PTGS1 Gene that Causes a Loss of a Glycan in the Catalytic Domain, Defects in Platelet Thromboxane A2 Synthesis, and Bleeding
-
Abstract Number: PB0194
Identification of Key Residues in Protein Z Dependent Protease Inhibitor (ZPI) for Efficient Protease Inhibiton
-
Abstract Number: PB1914
Identification of microRNAs Potentially Involved in Primary Antiphospholipid Syndrome Related Thrombosis
-
Abstract Number: PB0831
Identification of Novel Genetic Risk Factors in the Conserved Haplotype Region Surrounding the LCT Locus on Chromosome 2q21
-
Abstract Number: PB0174
Identification of Novel Proteins Binding to Coagulation Factor XIII Free B-Subunit
-
Abstract Number: PB2278
Identification of Somatic Mutations Associated with Clonal Hematopoiesis in Unprovoked Venous Thromboembolism
-
Abstract Number: PB0258
Identification of the Histidine-rich Glycoprotein Domain Responsible for Contact Pathway Inhibition
-
Abstract Number: PB1459
Identification of the Sequence Specificity in C-Src SH3 Required for Binding to Integrin Β3 as a Novel Anti-Thrombotic Target without Compromising Primary Hemostasis
-
Abstract Number: PB0151
Identification of Thrombosis Predictors in an ex vivo Shunt Model through Retrospective Analysis
-
Abstract Number: PB0329
Identification of Zebrafish Orthologue to Human Factor IX Gene and its Age Dependent Regulation
-
Abstract Number: PB0658
Identifying and Reducing the Cause of Haemolysis in Coagulation Blood Samples due to Sample Transport in a Pneumatic Tube System
-
Abstract Number: PB0691
Identifying DOACs in Mixing Study Samples
-
Abstract Number: PB1620
Ikaros/AhR Interaction Favors Expansion of Megakaryocytic Precursors with a High Potential to Produce Proplatelets
-
Abstract Number: PB1835
Immature Platelet Fraction and Platelet Indices in Acute Coronary Syndrome
-
Abstract Number: OC 03.1
Immune Profiling of Previously Untreated Patients with Severe Haemophilia A by High-throughput Mimotope Variation Analysis
-
Abstract Number: PB1356
Immune Thrombocytopenia Treatment with Fostamatinib, a Spleen Tyrosine Kinase Inhibitor: Reducing the Risk of Thrombosis
-
Abstract Number: PB1025
Immune Tolerance Induction (ITI) with a Plasma-derived Factor VIII for Patients with Hemophilia A and Inhibitors: A Retrospective Study
-
Abstract Number: PB1001
Immune Tolerance Induction (ITI) with a Single Factor VIII/von Willebrand Factor Concentrate in Haemophilia A Patients with Inhibitors – Update from the ObsITI Study
-
Abstract Number: PB1086
Immune Tolerance Induction in Children with Hemophilia A, in Times of Emicizumab: A Real Life Experience
-
Abstract Number: PB1044
Immune Tolerance Induction with Octanate® in Patients with Haemophilia A and Inhibitors: An Ongoing Case Series from a Malaysian Centre
-
Abstract Number: PB1047
Immune Tolerance Induction with Simoctocog Alfa in Patients with Haemophilia A: An Ongoing Multicentre Case Series from the UK
-
Abstract Number: PB2000
Immunization with Recombinant Atherogenic Antigen (AHC) Does Not Enhance Susceptibility to Sepsis
-
Abstract Number: PB0143
Immunization with Recombinant Atherogenic Antigen (AHC) Does Not Increase Susceptibility to Venous Thrombosis
-
Abstract Number: PB2282
Immuno-Magnetic Separation (IMS) Allows Efficient and Selective Extraction of Microvesicles Bearing Tissue Factor Activity from Various Liquid Biopsies
-
Abstract Number: PB0027
Immuno-Radio-Metric TSH in TRH Test of Optimal Substitutive Thyroid Hormones
-
Abstract Number: PB2483
Impact Analysis of Prognostic Stratification for Pulmonary Embolism (iAPP): A Randomized Controlled Trial
-
Abstract Number: PB2562
Impact of 399C/T Polymorphism of Tissue Factor Pathway Inhibitor on Risk of Recurrent Pregnancy Loss in India
-
Abstract Number: PB0975
Impact of a New Drug in the Real Child´s Life
-
Abstract Number: PB1281
Impact of a Perioperative Venous Thromboembolism Prophylaxis Screening Tool for Pediatric Orthopedic Surgical Patients
-
Abstract Number: PB1242
Impact of a Standardized, Moderate-Intensity Aerobic Exercise Regimen on Hemostasis in Adolescent Hemophilia A Carriers: A Pilot Investigation
-
Abstract Number: PB0701
Impact of Anticoagulant and of Time Elapsed Since Blood Collection on Platelet Function Assessed by Multiple Electrode Impedance Aggregometry
-
Abstract Number: PB0812
Impact of APTT Reagents on Factor VIII Assay in Plasma Spiked with a Pegylated Recombinant FVIII: A French Multicentre Study
-
Abstract Number: PB2289
Impact of Beta-Blockers on the Clinical Diagnosis of Patients with Pulmonary Embolism
-
Abstract Number: PB1313
Impact of Blood Group on the Incidence of Thrombosis in Neonates
-
Abstract Number: PB0634
Impact of Centrifugation on Thrombin Generation Analysis Evaluated in Healthy Subjects and Patients Treated with Direct Oral Anticoagulants
-
Abstract Number: PB2324
Impact of Clostridium Difficile Infections on In-Hospital Outcomes of Venous Thromboembolism (DVT or PE) Hospitalizations
-
Abstract Number: PB0537
Impact of Combination of Factor VIII-Deficient Plasma and Activator in One-Stage Clotting Assay on Potency Testing of Factor VIII Products
-
Abstract Number: PB2327
Impact of Competing Risk of Death on the Cumulative Incidence of Venous Thromboembolism in a Nationwide Danish Cohort of Men and Women
-
Abstract Number: PB0163
Impact of DOACs on Hemostasis Diagnostic Tests. Practical Recommendations and Guidance for the Laboratory
-
Abstract Number: PB1059
Impact of Extended Half-life Product versus Conventional Factor Product in Children with Hemophilia A – Findings from a Tertiary Care Centre
-
Abstract Number: PB0034
Impact of Gut Microbiota on Late Atherosclerosis and Atherothrombosis: A Study with Germ-Free Mice
-
Abstract Number: PB1287
Impact of Inherited Thrombophilia on Risk of a First Perinatal Arterial Stroke and Futher Course or Recurrence Rates: A Systematic Review and Meta-Analysis of Observational Studies
-
Abstract Number: PB1261
Impact of Intravenous Iron Therapy in Post-menarchal Adolescents Hospitalized with Acute Heavy Menstrual Bleeding
-
Abstract Number: PB1615
Impact of Irradiation on the Bone Marrow Matrix and Megakaryopoiesis
-
Abstract Number: PB2156
Impact of Obesity in Pulmonary Embolism among Patients with Solid Malignancies
-
Abstract Number: OC 01.5
Impact of Platelet-Selective TGF-β1-Deficiency in Atherogenesis and CD4+ T Effector Responses Using a No-Germline Genetic Engineering Atherosclerosis Mouse Model
-
Abstract Number: PB1039
Impact of Prophylactic Treatment Incorporation in Hemophilia A and B Hospitalization Rates of the State of São Paulo Patients – Brazil – from 2008 to 2018
-
Abstract Number: PB0091
Impact of Protease Nexin-1 in Cerebral Ischemia
-
Abstract Number: OC 12.3
Impact of SERPINC1 Mutation on Thrombotic Phenotype in Children with Congenital Antithrombin Deficiency – First Analysis of the International Society on Thrombosis and Hemostasis (ISTH) Pediatric AT Database and Biorepository
-
Abstract Number: PB2322
Impact of Socioeconomic Status on the Risk of Receiving a Permanent Work-Related Disability Pension After Incident Venous Thromboembolism
-
Abstract Number: PB0981
Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient Reported Outcomes in People with Haemophilia B Using the PROBE Questionnaire
-
Abstract Number: PB1891
Impact of Ultralarge von Willebrand Factor (VWF) Multimers and Platelets in Cultured Endothelial Cells in Acute Immune-mediated Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB2544
Impaired Platelet Contractility in Women with a History of Miscarriage
-
Abstract Number: PB2488
Implementation of a Text-message Intervention to Warfarin Users in a Brazilian Primary Care Setting
-
Abstract Number: PB1217
Implementation of Prefilled Doses- A Novel Approach to Decrease Medication Time to Administration and Errors In Critically Ill Pediatric Patients of Emergency Department (ED)
-
Abstract Number: PB0282
Implementation of the Management of Anticoagulation in the Periprocedural Period (MAPPP) App into an Electronic Health Record (EHR): A Prospective Cohort Study
-
Abstract Number: PB1687
Implication of Platelet Adhesiveness in the Risk of Venous Thromboembolic Disease
-
Abstract Number: PB0961
Implication of Weight Excess in Hemophilic Arthropathy. The Results of a Colombian Reference Center
-
Abstract Number: PB0040
Importance of Arginase-1 in Erythrocytes for Smooth Muscle Cell Calcification and Atherosclerosis
-
Abstract Number: PB1639
Importance of Platelet Contractility at Different Stages of Thrombus Formation
-
Abstract Number: PB0252
Importance of the Non-Catalytic Heavy Chains of the Homologs Factor XII and HGFA in Protease Function
-
Abstract Number: PB1764
Important Role for SHARPIN in Supporting Platelet Linear Ubiquitination and Thrombus Formation
-
Abstract Number: PB1202
Important Sex Differences in Patients with Autosomal Inherited Bleeding Disorders
-
Abstract Number: PB1274
Improve the Quality of Life in Children with Thrombosis and Need for Oral Anticoagulation: The “Coagulin Project”
-
Abstract Number: PB0002
Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated αIIbβ3 Antagonist, Disintegrin
-
Abstract Number: PB0480
Improved Functional and Biochemical Characteristics of Buffy-Coat Platelet Concentrates Stored in Citrate-Free PAS-III Additive Solution for 7 Days
-
Abstract Number: PB0937
Improved Prophylaxis Adherence After Switching to Emicizumab: Real-World Data from a Single Center
-
Abstract Number: PB1130
Improved Sensitivity of Global Hemostasis Assays Using Different Combinations of Phospholipid Reagent and Tissue Factor
-
Abstract Number: PB2457
Improvements in Short- and Long-term Outcomes in Patients with Pulmonary Embolism after Outpatient Pulmonary Rehabilitation
-
Abstract Number: PB0667
Improving Comparability of Optical Aggregometry Results from Automated Coagulation Analyzer Systems Compared with a Manual Aggregometer
-
Abstract Number: PB1089
In the Future, Will ADSCs Become the Target Cells for Hemophilia A Gene Therapy?
-
Abstract Number: PB2019
In Vitro Disruption of Endothelial Barrier Integrity by Heme and by Serum from Patients with Sickle Cell Disease
-
Abstract Number: PB0031
In vitro Occlusive Clot Growth and Retraction
-
Abstract Number: PB1716
In-Depth Platelet Releasate Proteome Profiling: A Novel Source of Biomarkers for Early-Onset Preeclampsia
-
Abstract Number: PB0016
In-Vivo Biomarkers of Platelet Function in Women with Ischemic Heart Disease: What We Learned from the EVA Study
-
Abstract Number: PB0264
In-vivo Evidence for Contact Activation after Implantation of a Left Ventricular Assist Device in Patients with End-stage Heart Failure
-
Abstract Number: PB0238
Inactivation of Tissue Factor Pathway Inhibitor through Specific Citrullination by Peptide Arginine Deiminase 4
-
Abstract Number: PB2082
Inappropriate Dosing of Direct Oral Anticoagulants in Older Patients with Non-Valvular Atrial Fibrillation: Impact on Plasma Drug Levels
-
Abstract Number: PB2109
Incidence and Risk Factors for Venous Thromboembolism (VTE) among Lymphoma Patients in a Southeast Asian Population
-
Abstract Number: PB2362
Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Bariatric Surgery
-
Abstract Number: PB2330
Incidence of Chronic Thromboembolic Pulmonary Hypertension: Results from a Longitudinal Prospective Cohort (Osiris Study)
-
Abstract Number: PB0998
Incidence of Factor VIII and IX Inhibitors in Hemophilia A and B in China
-
Abstract Number: PB0880
Incidence of Neutralizing Antibody (Inhibitor) in Previously Untreated Patients (PUPs) with Severe Hemophilia A
-
Abstract Number: PB0112
Incidence of Recurrent Ischemic Stroke in Patients without Atrial Fibrillation: A Real-world Study
-
Abstract Number: LB/CO01.3
Incidence of Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalisation
-
Abstract Number: PB0867
Incidence, Presentation and Management of Pseudotumors in Hemophilics: A Systemic Review
-
Abstract Number: PB2162
Incidence, Risk Factors and Clinical Outcome of Venous and Arterial Thromboembolic Events in Patients Treated with Immune-checkpoint Inhibitors: A Single-center Cohort Study
-
Abstract Number: PB2298
Incidental Pulmonary Embolism in an Internal Medicine Department
-
Abstract Number: PB1090
Increase in the Treatment Efficacy of Genome Editing for Hemophilia B by Codon-Optimization of SaCas9 in Mice
-
Abstract Number: PB1899
Increased Baseline Platelet Activation and Decreased Platelet Reactivity in Patients with the Antiphospholipid Syndrome
-
Abstract Number: PB2110
Increased Coagulation Potential in Patients with Polycythemia Vera and Essential Thrombocythemia with Thrombotic History
-
Abstract Number: PB/CO15
Increased Doses of Low-molecular-weight Heparin in Hospitalized Patients with Covid-19
-
Abstract Number: PB2226
Increased Levels of Procoagulant Factors and the Risk of Venous Thromboembolism
-
Abstract Number: PB0128
Increased Levels of von Willebrand Factor Associated with Acute Inflammation Contribute to Enhanced Venous Thrombosis
-
Abstract Number: PB0830
Increased Plasmin Generation in People with Severe Haemophilia
-
Abstract Number: PB2118
Increased Potential of Neutrophil Activation and Neutrophil Extracellular Trap Formation in Patients with Lung Cancer
-
Abstract Number: PB1563
Increased von Willebrand Factor Levels in Polycythemia Vera and Phenotypic Differences with Essential Thrombocythemia
-
Abstract Number: PB1578
Increasing Levels of von Willebrand Factor (VWF) and Factor VIII (FVIII:C) with Age in Patients Affected by von Willebrand Disease (VWD)
-
Abstract Number: PB0272
Indiscriminate Coagulation Testing for Bleeding Risk Assessment Prior to Orthopedic Surgery. Is it a Rational Approach?
-
Abstract Number: OC 14.4
Induction of Innate Immune Memory in Macrophages Profoundly Enhances their Procoagulant and Antifibrinolytic Activity
-
Abstract Number: PB1521
Inertial Forces Generated by a Vortex System Promote Cleavage of von Willebrand Factor
-
Abstract Number: PB2405
Inferior Vena Cava Filter (IVCF) Utilization: Quality Assurance at a Quaternary Care Medical Center
-
Abstract Number: PB1249
Inflammation Associated Cell-Free microRNA Levels in Cerebrospinal Fluid of Premature Infants Upon Intraventricular Hemorrhage
-
Abstract Number: PB0844
Inflammation in Hemophilia Is Marked by Up-regulation of LPS-binding Protein
-
Abstract Number: PB0515
Influence of Anticoagulants on the Biomechanical Phenotype of Platelets
-
Abstract Number: PB0446
Influence of Antiphospholipid Antibodies on Arterial Thrombosis in Myeloproliferative Neoplasia Patients: One Centre Experience
-
Abstract Number: PB1761
Influence of Bile Acids on Hemostasis and Arterial Thrombosis
-
Abstract Number: PB2311
Influence of Body Mass Index on Outcomes in Patients with Venous Thromboembolism: Insights from GARFIELD-VTE
-
Abstract Number: PB0633
Influence of DOAC Remove on Coagulation Assays During Thrombophilia Testing in Patients Treated with Rivaroxaban or Dabigatran
-
Abstract Number: PB1840
Influence of HOCl-modified Myeloperoxidase on Platelet and Neutrophil Activity
-
Abstract Number: PB1108
Influence of N-linked Glycosylation in the A and C Domains on the Immunogenicity of Factor VIII
-
Abstract Number: PB1879
Influence of Personality and Life Conditions on Depression, Anxiety and Cognitive Performance in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Abstract Number: PB0584
Influence of Phospholipids on the Measurement of Extended Half-Life Factor VIII Activity in One-Stage Clotting Assay
-
Abstract Number: PB0367
Influence of Specific Therapy on Microparticle-Associated Thrombin Generation in Patients with Primary Myelofibrosis
-
Abstract Number: PB2151
Influence of Tumor Site on Clinical Outcomes in Cancer Patients with Venous Thromboembolism. Insights from the Prospective PREDICARE Cohort Study
-
Abstract Number: PB0690
Inherited Coagulopathies Study by Massive Sequencing (NGS) Experience of a Diagnostic Portuguese Center
-
Abstract Number: PB2236
Inherited Deficiency of Antithrombin, Protein C or Protein S Is Associated with an Increased Risk of Cancer at a Younger Age
-
Abstract Number: PB1212
Inherited Factor VII Deficiency Associated with Thrombo-hemorrhagic Phenotype: A Case Report
-
Abstract Number: PB1197
Inherited Factor VII Deficiency in Women: Low Rate of Bleeding in Non-severe Disease
-
Abstract Number: PB1494
Inherited Platelet Disorders: Identification of Novel Disease Causing Variants Using Next Generation Sequencing
-
Abstract Number: PB1174
Inherited Rare Bleeding Disorders in Non-Consanguinity
-
Abstract Number: PB1450
Inherited Thrombocytopenia Associated with Haematological Malignancies
-
Abstract Number: PB1425
Inhibition of 12-LOX with VLX-1005 Has Clinical Utility for Prevention and Intervention of HIT
-
Abstract Number: PB1559
Inhibition of ADAMTS13 Rescues Acquired von Willebrand Syndrome in a Preclinical Mechanical Circulatory Support Animal Model
-
Abstract Number: PB0407
Inhibition of Factor Xa by Specific Reversible Inhibitors Is Selective for Factor Xa Generated by Factor IXa
-
Abstract Number: PB1460
Inhibition of Platelet Adhesion, Thrombus Formation and Fibrin Formation by a Potent αIIbβ3 Integrin Inhibitor
-
Abstract Number: PB0398
Inhibition of Protein Disulfide Isomerase (PDI) with PACMA-31 Amplifies LPS-Induced Expression of Tissue Factor (TF) in Monocytes
-
Abstract Number: PB0153
Inhibitor against Congenital Coagulation Factor XIII Deficiency: A Case Report
-
Abstract Number: PB1192
Inhibitor Development in a Patient with Severe Congenital Factor V Deficiency
-
Abstract Number: PB1013
Inhibitor Development in Hemophilia A – Refining the Risk Assessment
-
Abstract Number: PB1575
Inhibitor Development in Patients with Type 3 von Willebrand Disease, a Comprehensive Study on a Large Number of Iranian Patients
-
Abstract Number: PB1083
Inhibitor Epidemiology among People Living with Haemophilia A in South West Nigeria
-
Abstract Number: PB1079
Inhibitor Formation and Immune Tolerance Induction with Fc-fusion-Protein Recombinant Factor IX in Severe Hemophilia B
-
Abstract Number: PB0325
Inhibitor Risks Estimation Associated with F9 Genotype Types in Patients with Severe Haemophilia B: Argentine vs EAHAD Database
-
Abstract Number: PB0913
Inhibitors in Hemophilia: Treatment Challenges in Afghanestan
-
Abstract Number: PB1887
Inhibitory Anti Adamts13 Antibodies with a New Rapid Fully Automated Clia Assay
-
Abstract Number: PB1993
Inhibitory Effect of Heparin and Modified Heparin on Neutrophil Migration
-
Abstract Number: PB1416
Insights into Autoimmune Heparin-Induced Thrombocytopenia
-
Abstract Number: PB0684
Institutional Review of Reflex Factor Coagulation Testing in Patients with an Unexplained Prolonged aPTT
-
Abstract Number: PB0525
Inter-Centre and Inter-Observer Agreement of Determination of DOACs in Urine Samples of Patients by Means of DOAC Dipstick Test
-
Abstract Number: PB0386
Inter-Laboratory Variability of the Standardized ETP-Based APC Resistance Assay
-
Abstract Number: PB1646
Interaction between Platelets and Streptococcus pneumoniae
-
Abstract Number: PB1415
Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies as Investigated in Platelet Aggregation Assays
-
Abstract Number: PB0494
Interest of Improved Z-Score Bivariate Analysis: Application to a ECAT DDimer Survey
-
Abstract Number: PB0695
Interference of C – Reactive Protein Level in Activated Partial Thromboplastin Time
-
Abstract Number: PB1760
Interplay between the Tyrosine Kinases Chk, Csk and Phosphatase CD148 Is Critical for Regulating Platelets in Mice
-
Abstract Number: PB0014
Interventions Needed in Antithrombotic Therapy in a Real Life Hospitalized Population; Evaluation of Interventions Initiated by a Multidisciplinary Antithrombotic Team Regarding Antithrombotic Agent Combinations in In-Patient Care
-
Abstract Number: PB1407
Intra-individual Residual Platelet Reactivity upon Antiplatelet Therapy in the Perioperative Period Significantly Differs over Time – What Is the Ideal Moment to Monitor Efficacy of Antiplatelet Therapy in Vascular Patients?
-
Abstract Number: PB2087
Intracardiac Levels of Soluble P Selectin Is Associated with Ischemic Stroke Risk in Patients with Atrial Fibrillation
-
Abstract Number: PB0850
Intracellular Visualization of FVIII Protein in Selected Knockouts in the Conventional and Alternative Secretion Pathways
-
Abstract Number: PB2116
Intracranial Hemorrhage with Direct Oral Anticoagulants in Patients with Brain Metastases
-
Abstract Number: PB0026
Intravenous Lipid-Based Encapsulated Paclitaxel Nanoparticles Administration Enhances 5-Aminolevulinic Acid- Mediated B- Mode Ultrasound- Guided Focused- Electrohydraulic Shock Wave Sonodynamic Therapy of Intermediated Stage Atherosclerosis
-
Abstract Number: PB1139
Intravenous Synthetic Platelet Nanotechnology for the Treatment of Bleeding Complications
-
Abstract Number: PB1531
Investigating Pathomolecular Mechanisms of Type 2A VWD Variants Located in D1 and A Domains of the VWF
-
Abstract Number: PB1544
Investigating the Relationship between VWF Multimeric Pattern and VWF: RCo Activity through Population PK Modeling in Patients with Severe VWD Treated with Recombinant VWF
-
Abstract Number: PB1102
Investigating the Stability of Lentiviral Vector Targeted Liver Cells during Post-Natal Growth for in Vivo Gene Therapy of Hemophilia
-
Abstract Number: PB2036
Investigation of a Significant Factor to Improve an Establishment of Endothelial Colony Forming Cell
-
Abstract Number: PB2522
Investigation of Risk Factors of Deep Vein Thrombosis during Pregnancy Using a CFD Model
-
Abstract Number: PB0308
Investigation of Several Four Factor PCCs to Restore Thrombin Generation Following Anticoagulation with Rivaroxaban: Ex vivo Study
-
Abstract Number: PB0300
Investigation of the Coagulation Potential of PAS-E Resuspended Platelets
-
Abstract Number: PB2446
Investigation of the Optimal Dose of aPCC in Reversing the Effect of Factor Xa Inhibitors Rivaroxaban and Apixaban- an in vitro Study
-
Abstract Number: PB1376
Investigations of the Impact of Sialidase-mediated Changes on the Life Span of Human Platelets Using a Humanized in vivo Mouse Model
-
Abstract Number: PB1040
Is intracranial haemorrhage in haemophilia patients still a present risk in the third millennium? The final results of the EMO.REC Registry: a 10-year Italian study on intracranial haemorrhage in haemophilia patients
-
Abstract Number: PB2355
Is Low Molecular Weight Heparin-Calibrated Chromogenic Anti-Xa Assay Suitable for Assessing Anticoagulant Effect of Apixaban in Adolescents?
-
Abstract Number: PB2233
Is May-Thurner Syndrome a Forgotten Cause of Deep Vein Thrombosis?
-
Abstract Number: PB1824
Is Platelet Hyper-Reactivity a Modifiable Risk Factor in Inflammatory Arthritis?
-
Abstract Number: PB1084
Is Radiosynovectomy a Tool in Advanced Hemophilic Arthropathy?
-
Abstract Number: PB2373
Is the Caprini Score a Reliable Tool to Predict the Risk of Venous Thrombosis in Orthopedic Patients?
-
Abstract Number: PB1881
Is Therapeutic Plasma Exchange (TPE) Still Necessary for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)?
-
Abstract Number: PB2265
Is There a Predictive Value of High Mean Platelet Volume in Early Diagnosis of Venous Thromboembolism in the Emergency Department?
-
Abstract Number: PB1280
Ischemic Strokes in Children
-
Abstract Number: PB1168
Isolated Factor VII Deficiency
-
Abstract Number: PB1246
Isolated Thrombocytopenia in Children Is Not Always an Immune-Associated Disorder
-
Abstract Number: PB0615
ISTH SSC Plasma Standard Lot #5 – Results in a UK National External Quality Assessment Scheme for Blood Coagulation (NEQAS BC) Exercise
-
Abstract Number: PB1906
IVF Outcomes in Women with Antiphospholipid Antibodies Circulation
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.